Dong X - Search Results

1

Baseline staging tests based on molecular subtype is necessary for newly diagnosed breast cancer.

Chen X, Sun L, Cong Y, Zhang T, Lin Q, Meng Q, Pang H, Zhao Y, Li Y, Cai L, Dong X. Chen X, et al. Among authors: dong x. J Exp Clin Cancer Res. 2014 Mar 17;33(1):28. doi: 10.1186/1756-9966-33-28. J Exp Clin Cancer Res. 2014. PMID: 24628817 Free PMC article.

2

Prognostic values of osteopontin-c, E-cadherin and β-catenin in breast cancer.

Pang H, Lu H, Song H, Meng Q, Zhao Y, Liu N, Lan F, Liu Y, Yan S, Dong X, Cai L. Pang H, et al. Among authors: dong x. Cancer Epidemiol. 2013 Dec;37(6):985-92. doi: 10.1016/j.canep.2013.08.005. Epub 2013 Sep 5. Cancer Epidemiol. 2013. PMID: 24012693 Clinical Trial.

3

Luminal (Her2 negative) prognostic index and survival of breast cancer patients.

Chen X, Cong Y, Pan L, Jiang Y, Meng Q, Sun L, Pang H, Zhao Y, Dong X, Cai L. Chen X, et al. Among authors: dong x. Cancer Epidemiol. 2014 Jun;38(3):286-90. doi: 10.1016/j.canep.2014.03.007. Epub 2014 Apr 13. Cancer Epidemiol. 2014. PMID: 24725965

4

Efficacy and Safety of Nedaplatin in Advanced Breast Cancer Therapy.

Pang H, Feng T, Lu H, Meng Q, Chen X, Shen Q, Dong X, Cai L. Pang H, et al. Among authors: dong x. Cancer Invest. 2016;34(4):167-72. doi: 10.3109/07357907.2016.1144061. Epub 2016 Apr 8. Cancer Invest. 2016. PMID: 27057601

5

LRH1 promotes pancreatic cancer metastasis.

Lin Q, Aihara A, Chung W, Li Y, Chen X, Huang Z, Weng S, Carlson RI, Nadolny C, Wands JR, Dong X. Lin Q, et al. Among authors: dong x. Cancer Lett. 2014 Aug 1;350(1-2):15-24. doi: 10.1016/j.canlet.2014.04.017. Epub 2014 Apr 24. Cancer Lett. 2014. PMID: 24769073 Free PMC article.

6

Angiotensin II type 1 receptor antagonists inhibit cell proliferation and angiogenesis in breast cancer.

Chen X, Meng Q, Zhao Y, Liu M, Li D, Yang Y, Sun L, Sui G, Cai L, Dong X. Chen X, et al. Among authors: dong x. Cancer Lett. 2013 Jan 28;328(2):318-24. doi: 10.1016/j.canlet.2012.10.006. Epub 2012 Oct 22. Cancer Lett. 2013. PMID: 23092556

7

ABCC3 as a marker for multidrug resistance in non-small cell lung cancer.

Zhao Y, Lu H, Yan A, Yang Y, Meng Q, Sun L, Pang H, Li C, Dong X, Cai L. Zhao Y, et al. Among authors: dong x. Sci Rep. 2013 Nov 1;3:3120. doi: 10.1038/srep03120. Sci Rep. 2013. PMID: 24176985 Free PMC article.

8

LRH1 as a driving factor in pancreatic cancer growth.

Lin Q, Aihara A, Chung W, Li Y, Huang Z, Chen X, Weng S, Carlson RI, Wands JR, Dong X. Lin Q, et al. Among authors: dong x. Cancer Lett. 2014 Apr 1;345(1):85-90. doi: 10.1016/j.canlet.2013.11.014. Epub 2013 Dec 11. Cancer Lett. 2014. PMID: 24333731 Free PMC article.

9

Ang II-AT1R increases cell migration through PI3K/AKT and NF-κB pathways in breast cancer.

Zhao Y, Wang H, Li X, Cao M, Lu H, Meng Q, Pang H, Li H, Nadolny C, Dong X, Cai L. Zhao Y, et al. Among authors: dong x. J Cell Physiol. 2014 Nov;229(11):1855-62. doi: 10.1002/jcp.24639. J Cell Physiol. 2014. PMID: 24692224

10

MiR-23a-mediated migration/invasion is rescued by its target, IRS-1, in non-small cell lung cancer cells.

Cao M, Li Y, Lu H, Meng Q, Wang L, Cai L, Dong X. Cao M, et al. Among authors: dong x. J Cancer Res Clin Oncol. 2014 Oct;140(10):1661-70. doi: 10.1007/s00432-014-1725-0. Epub 2014 Jun 5. J Cancer Res Clin Oncol. 2014. PMID: 24898878

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,732 results

Search Page

Filters